Clinuvel Completes Development of Proprietary ZEROKINTM Administration Device

Filing content

Clinuvel has completed the development of ZEROKINTM, a single-use subcutaneous administration device, and plans to pursue FDA 510(k) registration and appoint a commercial manufacturer.